IMMUNOBIOLOGY OF VARICELLA AND ZOSTER IN A PRIMATE MODEL
灵长类动物模型中水痘和带状疱疹的免疫生物学
基本信息
- 批准号:7578632
- 负责人:
- 金额:$ 79.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AnimalsAntibodiesAntigen-Presenting CellsAntigensAppearanceAutologousAxonal TransportBloodCCR6 geneCell Differentiation processCellsCellular ImmunityChickenpoxChronicConfocal MicroscopyDataDendritic CellsDifferentiation AntigensDown-RegulationElderlyExperimental Animal ModelFlow CytometryGangliaGene ExpressionHematogenous SpreadHerpes zoster diseaseHerpesviridaeHerpesvirus Type 3HomingHumanImmuneImmune responseImmunityImmunobiologyImmunocompromised HostImmunohistochemistryImmunologic FactorsImmunosuppressive AgentsIncidenceInfectionInfectious Skin DiseasesKnowledgeLifeLymphocyte SubsetMHC Class I GenesMacacaModelingMolecular ModelsMonkeysMonoclonal AntibodiesMyxoid cystNeurologicNeuronsPapioPathogenesisPharmaceutical PreparationsPhenotypePopulationPreventionPrimatesProteinsProtocols documentationReverse Transcriptase Polymerase Chain ReactionRoleRouteSensory GangliaSiteSkinT-Cell Immunologic SpecificityT-LymphocyteTNFSF11 geneTestingTimeTonsilTranscriptUp-RegulationVaccinia virusViremiaVirusVirus DiseasesVirus Latencyaging populationbasecell typechemokinecytokineenhanced green fluorescent proteinexperienceinfected B cellinterleukin-17Cinterleukin-19irradiationmemory CD4 T lymphocytemolecular modelingnervous system disorderprotein expressionreactivation from latencyreceptorresponse
项目摘要
Primary varicella zoster virus (VZV)infection produces chickenpox (varicella), after which virus becomes
latent in ganglia reactivates to produce zoster (shingles). Neurological complications of zoster are
increased in the aging population whose cell-mediated immunity to VZV is reduced. During varicella,
virus enters ganglia by hematogenous spread or by retrograde axonal transport from skin infected by
tonsillar memory CD4+ T cells. VZV-specific T cells are not essential to maintain latency in ganglia.
Virus latency and reactivation is probably regulated by an innate immune response involving cytokines or
chemokines. We developed an experimental animal model that parallels VZV infections in humans.
Natural infection of primates with simian varicella virus (SW) leads to ganglionic latency and reactivation
after irradiation and treatment with immunosuppressive drugs. Reactivation of SW is accompanied by
changes in cytokine levels and by appearance of T cell clusters adjacent to neurons in ganglia with
reactivated virus. These data provide the rationale for our hypothesis that both immune cells and
non-immune cells as well as cytokines released by these cells upon their interaction with
neurons are important determinants of the course of primary varicella, latency and reactivation.
To determine the route of SW infection of skin and sensory ganglia, we will identify the host cell types
and their role in the transport and establishment of SW infection in skin and in ganglia after primary
infection (Aim 1). Because, SW latency and reactivation in ganglia are more likely regulated by an
innate immune response involving cytokines, we will comparethe cytokine expression during latency
and reactivation in monkey ganglia (Aim 2). To identify the SW-specific T cell response in ganglia
during reactivation, we will identify the phenotype and specificity of T cells infiltrating ganglia
during SW reactivation (Aim 3). A comprehensive knowledge of the cell types and immunological
factors that influence the transport of SW from the site of primary infection to skin and sensory ganglia
along with an understanding of the local SVV-specific T cell response in ganglia during latency and
reactivation will identify potential targets for prevention of zoster in humans. The latter is of particular
importance in the rapidly increasing elderly and immunocompromised populations, who often
develop chronic and sometimes fatal neurological disease produced by VZV reactivation.
原发水痘带状疱疹病毒(VZV)感染会产生水痘(水痘),之后病毒会变成
潜伏在神经节中重新激活以产生带状疱疹(带状疱疹)。带状疱疹的神经系统并发症有
在对VZV的细胞免疫功能降低的老龄化人口中增加。在水痘期间,
病毒通过血源性传播或通过逆行轴突运输从感染的皮肤进入神经节
扁桃体记忆CD4+T细胞。VZV特异性T细胞不是维持神经节潜伏期所必需的。
病毒的潜伏和重新激活可能是由一种涉及细胞因子或
趋化因子。我们开发了一种与人类感染VZV相似的实验动物模型。
灵长类动物自然感染猴水痘病毒可导致神经节潜伏期和再激活
照射后给予免疫抑制药物治疗。软件的重新激活伴随着
神经节细胞因子水平的变化及邻近神经元的T细胞团的出现
重新激活的病毒。这些数据为我们的假设提供了理由,即免疫细胞和
非免疫细胞以及这些细胞在与其相互作用时释放的细胞因子
神经元是决定水痘发病过程、潜伏期和复活的重要因素。
为了确定皮肤和感觉神经节感染霉菌的途径,我们将鉴定宿主细胞类型
以及它们在皮肤和神经节原发感染中的传播和建立中的作用
感染(目标1)。因为,神经节中的软件延迟和重新激活更有可能由
涉及细胞因子的先天免疫反应,我们将比较潜伏期细胞因子的表达
和猴神经节的重新激活(目标2)。在神经节中识别Sw特异性T细胞反应
在重新激活过程中,我们将鉴定T细胞渗入神经节的表型和特异性
在软件重新激活期间(目标3)。全面的细胞类型和免疫学知识
影响Sw从原发感染部位向皮肤和感觉神经节转运的因素
以及对神经节中局部SVV特异性T细胞在潜伏期和
重新激活将确定预防人类带状疱疹的潜在靶点。后者是特别的
对迅速增长的老年人和免疫功能低下的人口的重要性,他们经常
患上由VZV重新激活引起的慢性、有时是致命的神经系统疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RAVI MAHALINGAM其他文献
RAVI MAHALINGAM的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RAVI MAHALINGAM', 18)}}的其他基金
Mechanisms of varicella virus-induced multisystem disease using a primate model
使用灵长类动物模型研究水痘病毒诱导的多系统疾病的机制
- 批准号:
9491549 - 财政年份:2009
- 资助金额:
$ 79.13万 - 项目类别:
Mechanisms of varicella virus-induced multisystem disease using a primate model
使用灵长类动物模型研究水痘病毒诱导的多系统疾病的机制
- 批准号:
10542748 - 财政年份:2009
- 资助金额:
$ 79.13万 - 项目类别:
Mechanisms of varicella virus-induced multisystem disease using a primate model
使用灵长类动物模型研究水痘病毒诱导的多系统疾病的机制
- 批准号:
10343677 - 财政年份:2009
- 资助金额:
$ 79.13万 - 项目类别:
Mechanisms of varicella virus-induced multisystem disease using a primate model
使用灵长类动物模型研究水痘病毒诱导的多系统疾病的机制
- 批准号:
10097969 - 财政年份:2009
- 资助金额:
$ 79.13万 - 项目类别:
IMMUNOBIOLOGY OF VARICELLA AND ZOSTER IN A PRIMATE MODEL
灵长类动物模型中水痘和带状疱疹的免疫生物学
- 批准号:
8636736 - 财政年份:
- 资助金额:
$ 79.13万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 79.13万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 79.13万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 79.13万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 79.13万 - 项目类别:
Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 79.13万 - 项目类别:
Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 79.13万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 79.13万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
- 批准号:
10639161 - 财政年份:2023
- 资助金额:
$ 79.13万 - 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
- 批准号:
10752441 - 财政年份:2023
- 资助金额:
$ 79.13万 - 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
- 批准号:
10867639 - 财政年份:2023
- 资助金额:
$ 79.13万 - 项目类别: